Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,300 | 68,002 | 69,868 | 73,371 | 24,271 |
| Receivables | 3,675 | 910 | 1,493 | 1,075 | 2,282 |
| Inventories | 73 | 57 | 59 | 60 | 21 |
| TOTAL | $70,820 | $72,400 | $74,728 | $77,556 | $27,614 |
| Non-Current Assets | |||||
| PPE Net | 192 | 40 | 38 | 37 | 22 |
| Intangibles | 8,755 | 8,968 | 9,074 | 8,974 | 8,874 |
| Other Non-Current Assets | 335 | 634 | 512 | 447 | 495 |
| TOTAL | $9,282 | $9,642 | $9,624 | $9,458 | $9,391 |
| Total Assets | $80,102 | $82,042 | $84,352 | $87,014 | $37,005 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,672 | 2,113 | 1,848 | 2,252 | 2,199 |
| Other current liabilities | 34 | 81 | 85 | 86 | 92 |
| TOTAL | $7,766 | $4,777 | $4,547 | $4,946 | $4,742 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,815 | 2,075 | 2,125 | 2,101 | 2,193 |
| Other Non-Current Liabilities | 17,759 | 14,548 | 15,144 | 14,094 | 15,763 |
| TOTAL | $19,350 | $17,339 | $18,458 | $17,894 | $19,052 |
| Total Liabilities | $27,116 | $22,116 | $23,005 | $22,840 | $23,794 |
| Shareholders' Equity | |||||
| Common Shares | 293,410 | 293,347 | 293,347 | 293,781 | 235,008 |
| Retained earnings | -334,619 | -327,708 | -326,229 | -323,222 | -322,659 |
| Other shareholders' equity | 94,195 | 94,287 | 94,229 | 93,615 | 100,862 |
| TOTAL | $52,986 | $59,926 | $61,347 | $64,174 | $13,211 |
| Total Liabilities And Equity | $80,102 | $82,042 | $84,352 | $87,014 | $37,005 |